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AA and 48% of Whites [p=0.12]). After adjustment, there was
no signiﬁcant difference in hand pain between AA and White
participants (aOR 0.9, 95% CI 0.7, 1.1).
Conclusions: AA women and men were less likely to have DIP,
PIP, or CMC1 OA than White women and men, but were equally
likely to report hand pain. Further study is needed to elaborate
potential explanations for the discordance between radiographic
hand OA in these joint groups and hand pain, particularly in
African Americans.
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Purpose: Public health physical activity guidelines, such as those
recommended by the US Surgeon General, are tied to time
spent in physical activity of moderate-to-vigorous (MV) inten-
sity. Accelerometer monitoring provides an objective assessment
of physical activity. The Physical Activity Scale for the Elderly
(PASE) is a validated self-reported measure of physical activity
that requires only a few minutes of participant time. While previ-
ous studies demonstrate a signiﬁcant correlation of PASE scores
with accelerometer counts in normal healthy volunteers (ranging
from 0.43 to 0.64), that relationship has not been examined in
the context of knee osteoarthritis (OA).
Objective: To evaluate whether PASE scores correlate with ob-
jectively measured time spent in moderate-to-vigorous activity
(MV) and to assess the relationship between PASE scores with
subjective and objective measures of function in individuals at
risk for or with radiographic knee OA with frequent knee symp-
toms.
Methods: We conducted a pilot study of physical activity mea-
surements in 54 persons (mean age 66, body mass index 28,
58% women) enrolled in the Osteoarthritis Initiative, a longitu-
dinal cohort study of biomarkers for incident and progressive
knee OA. Participants completed the PASE interview and wore
a uni-axial accelerometer (ActiGraph, Pensacola, FLA) for seven
consecutive days. Accelerometer counts were translated on a
minute-by-minute basis into activity intensity levels based on
Schwartz categories. The relationships between total activity
counts, total minutes of MV activity and number of MV sessions
of 8 minutes or more (MV8) with subjective [PASE and Short
Form (SF) 12] and objective (20 meter walk and chair stand)
measures were assessed.
Results: Participants spent an average of 25 minutes per day in
MV activity occurring in sessions of 8 minute or more (MV8), as
recommended by the US Surgeon General. PASE scores were
modestly correlated with accelerometer counts (r = 0.24) and
total minutes of MV intensity (r=0.29). However, PASE scores
are poorly correlated with MV8 (r=0.18). PASE scores only cor-
related with function measured by the 20 meter walk (Table 1).
In contrast, accelerometer measures (counts, MV, MV8) are sig-
niﬁcantly correlated with function measured subjectively by the
SF 12 and objectively by the 20 meter walk (excluding MV8) and
the chair stand test.
Conclusions: In subjects with knee OA, although PASE and
accelerometer (counts, MV) signiﬁcantly correlate with function
measured by the 20 meter walk, only objective measurements of
activity using an accelerometer signiﬁcantly correlate with SF12
Table 1. Correlation of physical activity measures with function, n=54
Function Measures PASE Accelerometer Measurements
Counts MV MV sessions
Intensity of 8 minutes+
Function Measures Correlation Correlation Correlation Correlation
SF12 physical function 0.13 0.29* 0.28 * 0.35 **
20 meter walk 0.30* 0.31* 0.28* 0.22
Chair stand (n=43) 0.13 0.43* 0.38* 0.45**
*p<0.05, **p<0.01.
and chair stand function measures. Future analyses that focus
on investigating relationships between physical activity and knee
OA should consider assessment of objective measures of MV
activity.
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Purpose: Pharmacologic therapy using simple or combinations
of analgesics helps relieve pain improving daily function in pa-
tients with osteoarthritis (OA). Although numerous studies and
meta-analyses have compared the efﬁcacy of individual or two
classes of drugs, a comprehensive summary is absent. Using a
standardized metric, we aimed at comparing the efﬁcacy of all
the major classes of drugs presently used in the treatment of
OA.
Methods: A Medline search from 1966 to 2006 was performed
to locate placebo or actively controlled trials of NSAIDs, Cox-II
inhibitors (Coxibs), Opiates and morphinomimetics (Opioid) and
Acetaminophen classes of drugs. We included trials which con-
tain both baseline (before treatment) and post-treatment scores
of global pain, assessed by Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC), Pain Intensity (PI),
or Multidimensional Health Assessment Questionnaire. The out-
come measure, the relative change (RC, or reduction) of pain was
estimated through dividing thechange by the baseline score. To
make measures obtained from different instruments and scales
comparable, all scores were standardized to a percentage scale
and weighted by the number of subjects in each study for pre-
sentation.
Results: Out of the 279 titles being reviewed, twenty-two studies
met our inclusion criteria (NSAIDS N=15, Coxibs N=6, Opioids
N=4, Acetaminophen N=5). The mean RC (SD) of pain was
calculated to be 39.0 (7.9) for Coxibs, 37.6 (10.3) for NSAIDS,
40.2 (6.1) for Opioids (morphine is not included) and 28.2 (5.0)
for Acetaminophen, with baseline (SD) mean scores of 65.0
(7.39), 57.2 (11.9), 79.5 (7.2) and 64.4 (7.4) respectively.
Conclusions: Using standardized percentage change, we ob-
tained a single efﬁcacy score for each of the four major categories
of analgesics measured by different instruments across various
trials. Our results suggest that Coxibs and Opioids are among
the most effective treatments, and the efﬁcacy might be affected
by the baseline level of pain.
